594 American Family Physician www.aafp.org/afp Volume 79, Number 7
April 1, 2009
Members of various family medicine departments develop articles for
“Complementary and Alternative Medicine.” This is one in a series
coordinated by Sumi Sexton, MD, and Benjamin Kligler, MD, MPH.
CRAIG SCHNEIDER, MD, is director of integrative medicine in the Depart-
ment of Family Medicine at Maine Medical Center in Portland. He received
his medical degree from the Columbia University College of Physicians and
Surgeons in New York, NY. Dr. Schneider completed a family medicine resi-
dency at Maine Medical Center and a fellowship in integrative medicine at
the University of Arizona in Tucson.
TIFFANY SEGRE, MD, practices family and integrative medicine in Gorham,
Maine. At the time the article was written, Dr. Segre was completing a
fellowship through the combined integrative medicine program at Maine
Medical Center and the University of Arizona in Tucson. She received her
medical degree from the Temple University School of Medicine in Philadel-
phia (Pa.). She completed a family medicine residency at Maine Medical
Center in Portland.
Address correspondence to Craig Schneider, MD, Maine Medical Cen-
ter, 22 Bramhall St., Portland, ME 04102. Reprints are not available
from the authors.
Author disclosure: Nothing to disclose.
1. Schardt D. Does tea ward off disease? Nutr Action Healthletter. 2007;
2. Patel SH. Camellia sinensis: historical perspectives and future prospects.
J Agromedicine. 2005;10(2):57-64.
3. Cabrera C, Artacho R, Giménez R. Beneﬁcial effects of green tea—
a review. J Am Coll Nutr. 2006;25(2):79-99.
4. Gross G, et al. A randomized, double-blind, four-arm parallel-group,
placebo-controlled Phase II/III study to investigate the clinical efﬁ-
cacy of two galenic formulations of Polyphenon E in the treatment
of external genital warts. J Eur Acad Dermatol Venereol. 2007;21(10):
5. U.S. Food and Drug Administration. Veregen (Kunecatechins) ointment,
15%. http://www.fda.gov/cder/foi/label/2006/021902lbl.pdf. Accessed
December 22, 2008.
6. Ahn WS, Yoo J, Huh SW, et al. Protective effects of green tea extracts
(polyphenon E and EGCG) on human cervical lesions. Eur J Cancer Prev.
7. Bushman JL. Green tea and cancer in humans: a review of the literature.
Nutr Cancer. 1998;31(3):151-159.
8. Sun CL, Yuan JM, Koh WP, Yu MC. Green tea, black tea and breast
cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis.
9. Sun CL, Yuan JM, Koh WP, Yu MC. Green tea, black tea and colorectal
cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis.
10. Kuriyama S, Shimazu T, Ohmori K, et al. Green tea consumption and
mortality due to cardiovascular disease, cancer, and all causes in Japan:
the Ohsaki study. JAMA. 2006;296(10):1255-1265.
11. Sun CL, Yuan JM, Lee MJ, et al. Urinary tea polyphenols in relation to
gastric and esophageal cancers: a prospective study of men in Shang-
hai, China. Carcinogenesis. 2002;23(9):1497-1503.
12. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Che-
moprevention of human prostate cancer by oral administration of green
tea catechins in volunteers with high-grade prostate intraepithelial neo-
plasia: a preliminary report from a one-year proof-of-principle study.
Cancer Res. 2006;66(2):1234-1240.
13. Choan E, Segal R, Jonker D, et al. A prospective clinical trial of green tea
for hormone refractory prostate cancer: an evaluation of the complemen-
tary/alternative therapy approach. Urol Oncol. 2005;23(2):108-113.
14. Kurahashi N, Sasazuki S, Iwasaki M, Inoue M, Tsugane S, for the
JPHC Study Group. Green tea consumption and prostate cancer risk
in Japanese men: a prospective study. Am J Epidemiol. 2008;167(1):
15. Kovacs EM, Lejeune MP, Nijs I, Westerterp-Plantenga MS. Effects of
green tea on weight maintenance after body-weight loss. Br J Nutr.
16. Diepvens K, Kovacs EM, Vogels N, Westerterp-Plantenga MS. Meta-
bolic effects of green tea and of phases of weight loss. Physiol Behav.
17. Westerterp-Plantenga MS, Lejeune MP, Kovacs EM. Body weight loss
and weight maintenance in relation to habitual caffeine intake and
green tea supplementation. Obes Res. 2005;13(7):1195-1204.
18. Nagao T, Hase T, Tokimitsu I. A green tea extract high in catechins
reduces body fat and cardiovascular risks in humans. Obesity (Silver
19. Tsubono Y, Tsugane S. Green tea intake in relation to serum lipid
levels in Middle-aged Japanese men and women. Ann Epidemiol.
20. Maron DJ, Lu GP, Cai NS, et al. Cholesterol-lowering effect of a theaﬂa-
vin-enriched green tea extract: a randomized controlled trial. Arch
Intern Med. 2003;163(12):1448-1453.
21. Gloro R, Hourmand-Ollivier I, Mosquet B, et al. Fulminant hepatitis dur-
ing self-medication with hydroalcoholic extract of green tea. Eur J Gas-
troenterol Hepatol. 2005;17(10):1135-1137.
22. Taylor JR, Wilt VM. Probable antagonism of warfarin by green tea. Ann
23. Navarro-Perán E, Cabezas-Herrera J, García-Cánovas F, Durrant MC,
Thorneley RN, Rodríguez-López JN. The antifolate activity of tea cat-
echins. Cancer Res. 2005;65(6):2059-2064.
Table 2. Key Points About Green Tea
Effective for treatment of genital warts
Conﬂicting evidence for prevention and treatment of cancer
Conﬂicting evidence for weight loss
Possibly effective for prevention of stroke
Conﬂicting evidence for decreasing risk of cardiovascular
Central nervous system stimulation; gastrointestinal upset; case
reports of hepatotoxicity involving green tea extract in pill or
Topical ointment may cause local irritation
Additive effect with stimulants (caffeine component)
Available as tea, liquid and solid extracts, and ointment
Prices vary widely for tea and extracts by brand and quality,
but potentially as low as $5 to $18 for one-month supply;
ointment pricing varies by pharmacy, currently in $250 range
or higher for 15-g tube
Safe alternative to treat genital warts; inconsistent evidence for
use in cancer prevention, cardiovascular disease and stroke
prevention, and weight management
Information from references 4 through 21.